Evaluation of the therapeutic efficacy of a MEK inhibitor (TAK-733) using 18F-fluorodeoxyglucose-positron emission tomography in the human lung xenograft model A549
Crossref DOI link: https://doi.org/10.1007/s12149-015-0984-4
Published Online: 2015-05-27
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ishino, Seigo
Miyake, Hiroshi
Vincent, Patrick
Mori, Ikuo
License valid from 2015-05-27